Tagged with Taiwan

Taiwan Professor Shih-Hua Lin, president of Taiwan’s National Defense Medical Center, shares an overview of the academic and research environment of the institute as well as its role in cultivating the internationally connected talent that will drive Taiwan’s biomedical industry forward.   We must focus on how we can continue international…

Taiwan Scott Li, deputy director of H Spectrum, a biotech and talent incubator within the Foxconn group, explains the organization’s history and unique role in supporting Foxconn’s transition into healthcare. Li also shares his insights on the top challenges facing Taiwan’s innovation and entrepreneurial landscape.   H Spectrum is now positioned…

Taiwan William Foreman, president of AmCham Taipei, describes the attractiveness and challenges of Taiwan’s business landscape and the implications of US-China relations on the island. Foreman goes on to highlight the key issues facing the chamber’s healthcare members and concludes with a message about the necessary next steps to further enhance…

Taiwan Leo Liu, president of GeneReach Biotechnology Corp, shares the story of the diagnostics startup and explains his strategy to transition the company from a leading animal health point-of-care device manufacturer to a firm with a growing footprint in human health.   In Taiwan, startups can cooperate together to work on…

Taiwan Susan Hsu, managing director of Taiwanese data-driven CRO StatPlus, speaks about the key trends impacting Taiwan’s clinical trial environment and goes on to share her views on the increasing attractiveness of the island. Hsu concludes by explaining the service provider’s strategic position within APAC and its unique strength as a…

Taiwan Tony Chung, CEO of Instant NanoBiosensors explains the potential of their fibre-optic biosensor technology – FOPPR, and the commercialization strategy for their light-sensing biomarker analyzer INB-D200. He also highlights Taiwan’s strengths in developing value-added biomedical technology.   With the trend of precision medicine growing, innovative devices are needed to help…

Taiwan Shing-Mou Lee, founder and president of EMO Biomedicine, the leading CDMO provider of cell-based products in Taiwan, discusses the major regulatory and maturation trends in the region and shares his future strategy for expanding the company’s position in the sector.   One of EMO’s missions is to help the government…

Taiwan Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads as president, Chi Sheng Pharma & Biotech.   At this key moment, we in the pharmaceutical industry should make the…

Taiwan Ting-Kuo Lee, Academician of Academia Sinica and chairman of the Taiwan Nanotechnology Industry Development Association, explains the history and mission of the association to promote Taiwan’s nano sector and gives insights into the country’s unique capabilities as an early investor of the technology.   Nanomaterials such as nanoparticles have useful…

Taiwan Taiwan’s biotechnology industry was valued at USD 3.3 billion in 2016, representing around 26 percent of the island’s total biopharmaceutical market, along with pharmaceuticals and medical devices. Made with Visme Infographic Maker   The stock market capitalization of Taiwan’s biotech sector soared from USD 3.4 billion in 2007 to USD…

Taiwan An overview of all clinical trials conducted in Taiwan between 2011 and 2017. Made with Visme Infographic Maker   The number of clinical trials conducted in Taiwan during the period between 2011 and 2017 sorted by phase and by type of sponsor. By far the largest single category is Phase…

Taiwan HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then goes on to discuss the company’s innovative pipeline of stem cell therapies.   Overall, our offering will be a great…